FDA Approval: EPIDIOLEX (CANNABIDIOL) — Type 1 - New Molecular Entity
Policy FDA-NDA210365 · Neurology
Epidiolex, an oral cannabidiol solution, will fall under Medicare Part D for billing purposes. As it is an orphan drug, it may also have specific considerations for reimbursement and coverage. No J-co